Analyst firms · Morgan Stanley · AVRO

Morgan Stanley AVRO price target and rating history

AVROBIO Inc. (AVRO) · Health Care

Morgan Stanley rates AVROBIO Inc. (AVRO) Equal-Weight with a $3 price target, as of its latest action on Jan 5, 2022. It has published 4 rating actions on AVRO since July 2021, including 0 upgrades and 1 downgrade.

Current rating
Equal-Weight
Price target
$3
Median target, all firms
Too few
Actions on AVRO
4

Morgan Stanley price target on AVRO

$29$16$320222023202420252026
Morgan Stanley price target on AVRO, each point a stated target, July 2021 to January 2022.

Every Morgan Stanley rating on AVRO

Questions about Morgan Stanley and AVRO

What is Morgan Stanley's price target for AVRO?
Morgan Stanley's latest stated price target for AVROBIO Inc. (AVRO) is $3, from its action on Jan 5, 2022.
What is Morgan Stanley's rating on AVRO?
Morgan Stanley rates AVRO Equal-Weight, a neutral rating, as of Jan 5, 2022.
When did Morgan Stanley last change its view on AVRO?
On Jan 5, 2022, Morgan Stanley cuts its price target to $3 from $7, keeps Equal-Weight.

All Morgan Stanley ratingsAVRO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.